Use of oligo-quaternary compositions to increase scale inhibitor lifetime in a subterranean formation
View Patent ↗A method of inhibiting scale in a subterranean formation comprises pretreating the subterranean formation with a polyquaternary amine that serves as a squeeze life extension (SLE) agent, and then introducing a scale inhibitor pill into the subterranean formation, wherein the scale inhibitor pill includes one or more scale inhibitor compositions. For example, the polyquaternary amine may be a polymer having up to 5 quaternary amine centers, but is preferably a nonpolymeric diquaternary amine having a molecular weight of from 250 to 500. One such example is 1,3-propandiaminium, 2-hydroxy-N,N,N,N′,N′,N′-hexamethyl-, dichloride. The SLE agent is preferably introduced into the formation in a brine solution having a concentration from 0.1 to 20 weight percent. The SLE agents may be used with a variety of known scale inhibitors and scale inhibitor chemistries.
1. A composition for use in a spearhead treatment in a subterranean formation and in a wellbore connected thereto, comprising
(a) one or more nonpolymeric diquaternary amine salts comprising 2-hydroxy-N-(2-hydroxyethyl), N,N, N′,N′,N′-pentamethyl 1,3-propandiaminium dichloride; or 2-hydroxy-N,N-(2-hydroxyethyl), N,N′,N′,N′-tetramethyl 1,3-propandiaminium dichloride; and
(b) a brine comprising water and one or more salts comprising a sodium halide, a calcium halide, or a magnesium halide, wherein the brine has an electrical conductivity of greater than 0.1 mS/cm.
2. The composition of claim 1 , wherein the nonpolymeric diquaternary amine salt has a cation with a molecular weight of from about 170 to 1500.
3. The composition of claim 1 , wherein the nonpolymeric diquaternary amine salt is introduced into the formation in a brine solution having a nonpolymeric diquaternary amine salt concentration of from 0.1 to 20 weight percent.
4. The composition of claim 1 , wherein the nonpolymeric diquaternary amine salt is thermally stable to 180° C.
5. The composition of claim 1 , wherein the nonpolymeric diquaternary amine salt is introduced into the formation in a brine solution having a nonpolymeric diquaternary amine salt concentration of from 0.1 to 20 weight percent.
6. The composition of claim 1 , wherein the nonpolymeric diquaternary amine salt is symmetrical.
7. The composition of claim 1 , wherein the nonpolymeric diquaternary amine salt is non-symmetrical.
8. The composition of claim 1 , further comprising:
a scale inhibitor comprised of a scale inhibitor comprising at least one anionic group, a scale inhibitor comprising at least one phosphonate or phosphate ester group, a polymeric scale inhibitor comprising at least one carboxylate, phosphonate, or phosphonate ester group; or a polymeric scale inhibitor derived from monomers of formulae (I) or (II):
wherein R 3 is CO 2 Z, SO 3 Z, PO 3 Z 2 , or an alkyl or aryl group substituted with at least one CO 2 Z, SO 3 Z or PO 3 Z 2 group in which Z is a hydrogen atom or a univalent metal atom; and R 4 , R 5 and R 6 are each independently hydrogen, a substituted or unsubstituted alkyl or aryl group having from 1 to 8 carbon atoms, or an R 3 group.
9. The composition of claim 8 , wherein the cation in the nonpolymeric diquaternary amine has a molecular weight of from about 170 to 1500.
10. The composition of claim 8 , wherein the nonpolymeric diquaternary amine is introduced into the formation in a brine solution having a nonpolymeric diquaternary amine concentration of from 0.1 to 20 weight percent.
11. The composition of claim 8 , wherein the nonpolymeric diquaternary amine is thermally stable to 180° C.
12. The composition of claim 8 , wherein the nonpolymeric diquaternary amine is symmetrical.
13. The composition of claim 8 , wherein the nonpolymeric diquaternary amine is non-symmetrical.
14. The composition of claim 8 , wherein the scale inhibitor is a phosphonate.
15. The composition of claim 8 , wherein the scale inhibitor is a polymeric scale inhibitor.
16. The composition of claim 8 ,
wherein the scale inhibitor comprises BHMT phosphonate, DETA phosphonate, a phosphorus-containing polycarboxylate, a phosphorus-containing polymer, or a sulfonated polyacrylate.